Rechercher des projets européens

5 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 
The airways diseases asthma and chronic obstructive pulmonary disease affect over 400 million people world-wide and cause considerable morbidity and mortality. Airways disease costs the European Union in excess of €56 billion per annum. Current therapies are inadequate and we do not have sufficient tools to predict disease progression or response to current or future therapies. Our consortium, Air ...
Voir le projet

 40

 TERMINÉ 
Over the past 15 years, EU-funded cohorts and collaborations (EuroSIDA, CASCADE and PENTA), have played a central role in developing our understanding of HIV progression and the effects of ART, enabling European expertise to contribute directly to the advances in patient diagnosis and management worldwide, and providing a continued surveillance mechanism for detection of emerging problems at a Eur ...
Voir le projet

 26

 TERMINÉ 

Indoor Contamination with Flame Retardant Chemicals: Causes and Impacts (INFLAME)

Date du début: 1 janv. 2011, Date de fin: 31 déc. 2014,

"The main research goal is to further understanding of how and to what extent flame retardant (FR) chemicals used in every-day consumer goods and construction materials enter humans and of the risk to health that such exposure presents. Our vision is that this enhanced understanding will inform assessment of risk associated both with recent and current-use flame retardant chemicals, and of those u ...
Voir le projet

 11

 TERMINÉ 

Virtual GastrOintestinal tRact (VIGOR++)

Date du début: 1 févr. 2011, Date de fin: 31 mai 2014,

Inflammatory Bowel diseases (IBDs) constitute on of the largest healthcare problems in the Western World, affecting over 1 million European citizens alone, 700,000 of whom suffer from Crohn's disease.Grading of Crohn's disease severity is important to determine treatment strategy and to quantify the response to treatment. Colonoscopy in combination with the assessment of biopsy samples is consider ...
Voir le projet

 7

 TERMINÉ 
"The elicitation of broadly neutralising antibodies (Nab) remains the primary and most challenging goal in HIV-1 vaccine development. Although a few anti-HIV-1 monoclonal antibodies with broadly neutralising capability have been isolated from infected individuals, none of the immunization strategies thus far explored has proven effective in inducing similar antibodies. Objective of this applicatio ...
Voir le projet

 18